FDA Revokes Approval for Preterm Birth Drug Makena

被引：2

|

作者：

Harris, Emily

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 17期

关键词：

D O I：

10.1001/jama.2023.6257

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1444 / 1444

页数：1

相关论文

共 50 条

[31] RECENT FDA DRUG APPROVAL - TRANEXAMIC ACID
不详
CLINICAL PEDIATRICS, 1987, 26 (12) : 668 - 668
[32] FDA NEW DRUG APPROVAL POLICY - WHY
PATTERSON, R
GRAMMER, LC
NEW ENGLAND AND REGIONAL ALLERGY PROCEEDINGS, 1985, 6 (04): : 379 - 380
[33] The role of chemists in the FDA drug approval process
Furness, M. Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
[34] FDA: Evidentiary Standards for Drug Development and Approval
Katz R.
NeuroRX, 2004, 1 (3): : 307 - 316
[35] The FDA Accelerated Drug Approval Program Explained
Lisi, Donna M.
US PHARMACIST, 2023, 48 (10) : 46 - 55
[36] SB wins US FDA approval for drug
不详
EUROPEAN CHEMICAL NEWS, 1996, 65 (1720): : 23 - 23
[37] DRUG GROUP ASSESSES FDA APPROVAL PROCESS
EMBER, L
CHEMICAL & ENGINEERING NEWS, 1990, 68 (04) : 6 - 6
[38] PhRMA refutes FDA study on drug approval
Barnett, AA
LANCET, 1996, 347 (8996): : 254 - 254
[39] ISIS ANTISENSE DRUG WINS FDA APPROVAL
不详
CHEMICAL & ENGINEERING NEWS, 2013, 91 (05) : 14 - 14
[40] FDA unease about faster drug approval
Doshi, Peter
BMJ-BRITISH MEDICAL JOURNAL, 2017, 357

← 1 2 3 4 5 →